Krystal Biotech, Inc.KRYSNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$200.87M
↑ 7196% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$2.75M
Historical baseline
PeriodValueYoY Change
2025$200.87M+62.7%
2024$123.42M+239.0%
2023$-88.80M+11.7%
2022$-100.57M-109.8%
2021$-47.94M-83.8%
2020$-26.08M-39.4%
2019$-18.71M-98.1%
2018$-9.45M-142.8%
2017$-3.89M-196.7%
2016$-1.31M-